MAOB
Basic information
Region (hg38): X:43766610-43882450
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAOB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 16 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 16 | 5 | 4 |
Variants in MAOB
This is a list of pathogenic ClinVar variants found in the MAOB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-43767515-G-A | not specified | Uncertain significance (Apr 24, 2024) | ||
X-43767564-C-T | not specified | Uncertain significance (Jun 12, 2023) | ||
X-43767565-G-A | Likely benign (Mar 06, 2018) | |||
X-43767585-A-T | Likely benign (Mar 29, 2018) | |||
X-43767586-A-G | Benign (Mar 29, 2018) | |||
X-43767598-G-A | Likely benign (Feb 01, 2023) | |||
X-43768646-T-C | Benign (May 08, 2018) | |||
X-43775281-T-C | Likely benign (Mar 01, 2018) | |||
X-43781451-A-G | not specified | Uncertain significance (Mar 01, 2024) | ||
X-43781485-C-T | not specified | Uncertain significance (May 23, 2023) | ||
X-43793505-A-G | not specified | Uncertain significance (Feb 03, 2022) | ||
X-43793510-T-C | Benign (Apr 09, 2018) | |||
X-43795782-C-T | not specified | Uncertain significance (Mar 27, 2023) | ||
X-43797156-G-C | not specified | Uncertain significance (Oct 16, 2023) | ||
X-43797262-C-A | not specified | Uncertain significance (May 06, 2022) | ||
X-43802185-G-A | not specified | Uncertain significance (Mar 24, 2023) | ||
X-43802189-G-C | not specified | Uncertain significance (Apr 05, 2023) | ||
X-43802215-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
X-43802246-T-C | Benign (May 18, 2018) | |||
X-43802257-T-G | not specified | Uncertain significance (Nov 28, 2023) | ||
X-43803363-C-A | not specified | Uncertain significance (Dec 27, 2023) | ||
X-43838925-C-A | not specified | Uncertain significance (Dec 01, 2023) | ||
X-43838972-A-C | not specified | Uncertain significance (Nov 30, 2022) | ||
X-43843690-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
X-43843720-C-T | not specified | Uncertain significance (Sep 22, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAOB | protein_coding | protein_coding | ENST00000378069 | 15 | 115836 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.000966 | 125072 | 2 | 0 | 125074 | 0.00000800 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.75 | 118 | 185 | 0.638 | 0.0000135 | 3358 |
Missense in Polyphen | 18 | 64.934 | 0.2772 | 1111 | ||
Synonymous | -0.564 | 73 | 67.1 | 1.09 | 0.00000490 | 1010 |
Loss of Function | 4.16 | 0 | 20.1 | 0.00 | 0.00000147 | 375 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.000135 | 0.0000996 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000554 | 0.0000330 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine.;
- Pathway
- Tryptophan metabolism - Homo sapiens (human);Arginine and proline metabolism - Homo sapiens (human);Serotonergic synapse - Homo sapiens (human);Dopaminergic synapse - Homo sapiens (human);Phenylalanine metabolism - Homo sapiens (human);Histidine metabolism - Homo sapiens (human);Glycine, serine and threonine metabolism - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Amphetamine addiction - Homo sapiens (human);Tyrosine metabolism - Homo sapiens (human);Alcoholism - Homo sapiens (human);Cocaine addiction - Homo sapiens (human);Citalopram Action Pathway;Citalopram Metabolism Pathway;Dopamine metabolism;Tryptophan metabolism;Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB;Amine Oxidase reactions;Phase I - Functionalization of compounds;Glycine Serine metabolism;dopamine degradation;Tyrosine metabolism;Biological oxidations;Metabolism;Phenylalanine degradation;tryptophan degradation via tryptamine;Histidine metabolism;Tryptophan metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Arginine Proline metabolism;Tryptophan degradation;superpathway of tryptophan utilization;Tyrosine metabolism;noradrenaline and adrenaline degradation;Histidine degradation;Alpha-synuclein signaling;putrescine degradation III
(Consensus)
Recessive Scores
- pRec
- 0.481
Intolerance Scores
- loftool
- 0.0976
- rvis_EVS
- -0.63
- rvis_percentile_EVS
- 17.03
Haploinsufficiency Scores
- pHI
- 0.503
- hipred
- Y
- hipred_score
- 0.712
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.979
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Maob
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); renal/urinary system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- response to aluminum ion;response to selenium ion;negative regulation of serotonin secretion;substantia nigra development;electron transport chain;response to lipopolysaccharide;neurotransmitter catabolic process;dopamine catabolic process;response to ethanol;positive regulation of dopamine metabolic process;hydrogen peroxide biosynthetic process;response to corticosterone
- Cellular component
- mitochondrion;mitochondrial envelope;mitochondrial outer membrane;integral component of membrane
- Molecular function
- primary amine oxidase activity;electron transfer activity;protein homodimerization activity;flavin adenine dinucleotide binding